Task: Question Generation
Input (English): Essentials The platelet thrombin receptor, PAR4, is an emerging anti-thrombotic drug target. We examined the anti-platelet & anti-thrombotic effects of PAR4 inhibition in human blood. PAR4 inhibition impaired platelet procoagulant activity in isolated cells and during thrombosis. Our study shows PAR4 is required for platelet procoagulant function & thrombosis in human blood.
Output (English): Does inhibition of protease-activated receptor 4 impair platelet procoagulant activity during thrombus formation in human blood?